| Identification | Back Directory | [Name]
3-[[6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one, tris(2-hydroxyethyl) ether | [CAS]
31511-30-5 | [Synonyms]
3-[[6-O-(6-Deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one,tris(2-hydroxyethyl) ether | [EINECS(EC#)]
250-670-5 | [Molecular Formula]
C33H42O19 | [MOL File]
31511-30-5.mol |
| Questions And Answer | Back Directory | [Application]
Clinically applicable to hemiplegia and aphasia caused by cerebral thrombosis and cerebral embolism, as well as pre-myocardial infarction syndrome, arteriosclerosis, central retinitis, thrombophlebitis, varicose veins, and edema caused by increased vascular permeability. |
|
|